Examination concerning utility and safety of Cilostazol use in patients with PAD conplicated to CKD
Not Applicable
Recruiting
- Conditions
- PAD with CKD
- Registration Number
- JPRN-UMIN000003891
- Lead Sponsor
- Departmrnt of CKD initiatives,Nagoya university graduate school of medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1)Nephrotic syndrome 2)active bleeding 3)allergy for cilostazol and aspirin 4)platelet dysfunction 5)age under 20y.o.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method renal function(eGFR,cCRe), albuminuria and endothelial dysfunction
- Secondary Outcome Measures
Name Time Method intima-media thickness(IMT), ABI,TBI,serum lipid marker